Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
€ 3,31 ↓ -0.17 (-4.89%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionNorges Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Norges Bank closes position in 2LB / Iovance Biotherapeutics, Inc.

On August 13, 2025 - Norges Bank filed a 13F-HR form disclosing ownership of 0 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR/A on May 11, 2026 disclosing 260,148 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-13 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -260,148 -100.00 0 -100.00
2026-05-11 2025-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 260,148 -156,089 -37.50 866 -71.88 0.0001
2025-02-12 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 416,237 -350,808 -45.73 3,080 -57.23 0.0004
2025-11-12 2024-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 767,045 -175,938 -18.66 7,203 -4.76 0.0010
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 942,983 -149,004 -13.65 7,563 -53.27 0.0011
2025-05-14 2024-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,091,987 -28,470 -2.54 16,183 77.66 0.0026
2024-02-09 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,120,457 0 0.00 9,109 78.68 0.0016
2024-11-13 2023-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,120,457 0 0.00 5,098 -35.37 0.0010
2024-08-14 2023-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,120,457 -1,319,600 -54.08 7,888 -47.09 0.0016
2024-05-15 2023-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 2,440,057 -534,800 -17.98 14,909 -21.57 0.0033
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,974,857 1,578,500 113.04 19,009 42.10 0.0046
2023-11-13 2022-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,396,357 42,122 3.11 13,377 -10.52 0.0036
2023-08-14 2022-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,354,235 496 0.04 14,951 -33.67 0.0039
2023-05-12 2022-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,353,739 52,289 4.02 22,540 -9.28 0.0049
2022-03-09 2021-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,301,450 63,252 5.11 24,845 -18.63 0.0051
2022-11-14 2021-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,238,198 52,525 4.43 30,534 -1.03 0.0068
2022-08-15 2021-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,185,673 -38,743 -3.16 30,851 -20.42 0.0067
2022-05-09 2021-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,224,416 -248,215 -16.86 38,765 -43.27 0.0089
2021-03-02 2020-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,472,631 -57,523 -3.76 68,330 35.65 0.0160
2021-11-12 2020-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,530,154 80,375 5.54 50,373 26.58 0.0134
2021-08-13 2020-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,449,779 140,800 10.76 39,796 1.56 0.0115
2021-05-07 2020-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,308,979 0 0.00 39,184 8.14 0.0140
2020-03-03 2019-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 1,308,979 701,550 115.49 36,233 227.75 0.0101
2020-11-13 2019-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 607,429 587,429 2,937.14 11,055 2,156.12 0.0034
2020-08-13 2019-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 20,000 0 0.00 490 157.89 0.0002
2020-05-11 2019-03-31 13F/A-2 IOVANCE BIOTHERAPEUTICS COM 462260100 20,000 0 0.00 190 7.34 0.0001
2019-03-04 2018-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 20,000 20,000 177 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.